Zobrazeno 1 - 10
of 604
pro vyhledávání: '"Huntington SF"'
Autor:
Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT., Manzoor BS; AbbVie Inc., North Chicago, IL., Jawaid D; AbbVie Inc., North Chicago, IL., Puckett JT; COVIA Health Solutions, Ambler, PA., Emechebe N; AbbVie Inc., North Chicago, IL., Ravelo A; Genentech Inc., South San Francisco, CA., Kamal-Bahl S; COVIA Health Solutions, Ambler, PA., Doshi JA; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Oct; Vol. 30 (10), pp. 1106-1116. Date of Electronic Publication: 2024 Jul 24.
Autor:
Squires P; Merck & Co, Inc, Rahway, NJ., Puckett J; COVIA Health Solutions, Lansdale, PA. Electronic address: justin@coviahealthsolutions.com., Ryland KE; Merck & Co, Inc, Rahway, NJ., Kamal-Bahl S; COVIA Health Solutions, Lansdale, PA. Electronic address: sachin@coviahealthsolutions.com., Raut M; Merck & Co, Inc, Rahway, NJ., Doshi J; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Oct; Vol. 24 (10), pp. e350-e358.e1. Date of Electronic Publication: 2024 Jun 04.
Autor:
Bewersdorf JP; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Patel KK; Department of Medicine, Brigham and Women's Hospital, Boston, MA., Shallis RM; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT., Podoltsev NA; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT., Kewan T; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Stempel J; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Mendez L; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Stahl M; Department of Medical Oncology, Adult Leukemia Program, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA., Stein EM; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Huntington SF; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT., Goshua G; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT., Zeidan AM; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Department of Medical Oncology, Adult Leukemia Program, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Aug; Vol. 65 (8), pp. 1136-1144. Date of Electronic Publication: 2024 Apr 22.
Autor:
Di M; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.; Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale University, New Haven, CT, USA.; Division of Hematology and Oncology, Department of Medicine, University of Washington/Fred Hutchinson Cancer Center, Seattle, WA, USA., Potnis KC; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA., Long JB; Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale University, New Haven, CT, USA., Isufi I; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA., Foss F; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA., Seropian S; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA., Gross CP; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.; Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale University, New Haven, CT, USA., Huntington SF; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.; Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale University, New Haven, CT, USA.
Publikováno v:
JNCI cancer spectrum [JNCI Cancer Spectr] 2024 Jul 01; Vol. 8 (4).
Autor:
Huntington SF; Yale School of Medicine, New Haven, CT, USA., Cheng WY; Analysis Group, Inc, Boston, MA, USA., Sarpong EM; Merck & Co., Inc, Rahway, NJ, USA., Leng S; Merck & Co., Inc, Rahway, NJ, USA., Farooqui MZH; Merck & Co., Inc, Rahway, NJ, USA., Agu US; University of Arizona, Tucson, AZ, USA., Catillon M; Analysis Group, Inc, Boston, MA, USA., Lejeune D; Groupe d'analyse, Ltée, Montréal, QC, Canada., Downes N; Analysis Group, Inc, Boston, MA, USA., Matay L; Analysis Group, Inc, Boston, MA, USA., Duh MS; Analysis Group, Inc, Boston, MA, USA., De Nigris E; MSD (UK) Limited, London, UK.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Jul; Vol. 65 (7), pp. 932-942. Date of Electronic Publication: 2024 May 02.
Autor:
Garg M; Merck & Co., Inc., Rahway, NJ., Puckett J; COVIA Health Solutions, PA., Kamal-Bahl S; COVIA Health Solutions, PA. Electronic address: sachin@coviahealthsolutions.com., Raut M; Merck & Co., Inc., Rahway, NJ., Ryland KE; Merck & Co., Inc., Rahway, NJ., Doshi JA; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 May; Vol. 24 (5), pp. e181-e190. Date of Electronic Publication: 2024 Feb 09.
Autor:
Garg M; Merck & Co., Inc., Rahway, NJ 07065, USA., Puckett J; COVIA Health Solutions, Lansdale, PA 19446, USA., Kamal-Bahl S; COVIA Health Solutions, Lansdale, PA 19446, USA., Raut M; Merck & Co., Inc., Rahway, NJ 07065, USA., Ryland KE; Merck & Co., Inc., Rahway, NJ 07065, USA., Doshi JA; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT 06510, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Feb; Vol. 20 (6), pp. 317-328. Date of Electronic Publication: 2023 Dec 05.
Autor:
Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, Connecticut, USA., de Nigris E; MSD (UK) Limited, London, UK., Puckett JT; COVIA Health Solutions, Ambler, Pennsylvania, USA., Kamal-Bahl S; COVIA Health Solutions, Ambler, Pennsylvania, USA., Farooqui M; Merck & Co., Inc, Rahway, New Jersey, USA., Ryland K; Merck & Co., Inc, Rahway, New Jersey, USA., Sarpong EM; Merck & Co., Inc, Rahway, New Jersey, USA., Leng S; Merck & Co., Inc, Rahway, New Jersey, USA., Yang X; Merck & Co., Inc, Rahway, New Jersey, USA., Doshi JA; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Jan; Vol. 13 (2), pp. e6953.
Autor:
Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT, USA., Manzoor BS; AbbVie Inc, North Chicago, IL, USA., Puckett JT; COVIA Health Solutions, Lansdale, PA, USA., Kamal-Bahl S; COVIA Health Solutions, Lansdale, PA, USA., Alhasani H; AbbVie Inc, North Chicago, IL, USA., Ravelo A; Genentech Inc, South San Francisco, CA, USA., Jawaid D; AbbVie Inc, North Chicago, IL, USA., Doshi JA; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Dec; Vol. 64 (14), pp. 2316-2323. Date of Electronic Publication: 2023 Dec 25.
Autor:
Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT, USA., de Nigris E; Merck & Co., Inc., Rahway, NJ, USA., Puckett J; COVIA Health Solutions, Lansdale, PA, USA., Kamal-Bahl S; COVIA Health Solutions, Lansdale, PA, USA., Farooqui M; Merck & Co., Inc., Rahway, NJ, USA., Ryland K; Merck & Co., Inc., Rahway, NJ, USA., Sarpong E; Merck & Co., Inc., Rahway, NJ, USA., Leng S; Merck & Co., Inc., Rahway, NJ, USA., Yang X; Merck & Co., Inc., Rahway, NJ, USA., Doshi JA; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Dec; Vol. 64 (14), pp. 2286-2295. Date of Electronic Publication: 2023 Dec 25.